Health Condition 1: M513- Other thoracic, thoracolumbar andlumbosacral intervertebral disc degeneration
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adults aged between 18–65 years Patients with chronic low back pain for more than 3 months MRI evidence showing disc degeneration or annular tear Patients with failed conservative therapy of at least 3 months.
Exclusion criteria
Exclusion criteria: Patients with radiculopathy or spinal canal stenosis Patients who have undergone prior lumbar surgery Patients with spinal infection, tumors, fractures, or instability Currently on anti-coagulants or patients with coagulopathy Pregnant or lactating women Patients with known allergy to drugs and materials used .
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the analgesic efficacy of biaculoplasty + intradiscal leucocyte poor PRP and biaculoplasty + intradiscal steroid in patients with chronic discogenic low back pain at 3,6 and 12 months after the procedure using NRS (Numerical rating scale) Timepoint: To compare the analgesic efficacy of biaculoplasty + intradiscal leucocyte poor PRP and biaculoplasty + intradiscal steroid in patients with chronic discogenic low back pain at 3,6 and 12 months after the procedure using NRS (Numerical rating scale) | — |
Secondary
| Measure | Time frame |
|---|---|
| Compare functional improvement using the Oswestry Disability Index (ODI) in patients with chronic discogenic low back pain after biaculoplasty + intradiscal leucocyte poor PRP and biaculoplasty + intradiscal steroid at 3,6 and 12 months after the procedure. Evaluate quality of life changes using SF12 at 3,6 and 12months Assess patient satisfaction using Patient Global Impression of Change (PGIC) scale To identify predictors of treatment success in each group. Monitor adverse events. Timepoint: 3, 6, 12 months | — |
Countries
India
Contacts
All India Institute Of Medical Sciences, Bhopal